News

Xentria's latest news and updates about the development
of future biologics and biosimilars products

Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis

Important Regulatory Milestone Provides Runaway to Move XTMAB-16 into the Clinical Phase

Published on Mar 03 2021

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Published on Dec 15 2020